Tower Research Capital (TRC)’s Telomir Pharmaceuticals TELO Stock Holding History

Tower Research Capital (TRC)’s Portfolio TELO Stock Details TELO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$1.74K	Sell
2025 Q2	$10.8K	Buy
2025 Q1	$8.78K	Buy
2024 Q4	$9.7K	Buy
2024 Q3	$9.62K	Buy
2024 Q2	$4.56K	Buy